LYKA

Lyka Labs Ltd (LYKALABS)

Market Closed
12 Dec, 10:00
XNSE XNSE
77. 69
-0.63
-0.8%
4.4B Market Cap
- P/E Ratio
0% Div Yield
8,607 Volume
0 Eps
78.32
Previous Close
Day Range
77.1 80
Year Range
72.2 167.19
Want to track LYKALABS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 51 days

Summary

LYKALABS closed yesterday lower at ₹77.69, a decrease of 0.8% from Thursday's close, completing a monthly decrease of -6.06% or ₹5.01. Over the past 12 months, LYKALABS stock lost -51.35%.
LYKALABS is not paying dividends to its shareholders.
The last earnings report, released on Nov 10, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Feb 02, 2026.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

LYKALABS Chart

Similar

Max India Limited
191.4
-0.9%
Nova Agritech Ltd.
39.65
-0.23%
Balaxi Pharmaceuticals Ltd.
30.06
-8.96%
Nath Bio-Genes (India) Limited
153.3
+1.01%

Lyka Labs Ltd (LYKALABS) FAQ

What is the stock price today?

The current price is ₹77.69.

On which exchange is it traded?

Lyka Labs Ltd is listed on XNSE.

What is its stock symbol?

The ticker symbol is LYKALABS.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 4.4B.

When is the next earnings date?

The next earnings report will release on Feb 02, 2026.

Has Lyka Labs Ltd ever had a stock split?

No, there has never been a stock split.

Lyka Labs Ltd Profile

Biotechnology Industry
Healthcare Sector
Mr. Kunal Narendra Gandhi CEO
XNSE Exchange
INE933A01014 ISIN
IN Country
296 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Lyka Labs Limited is a prominent player in the pharmaceutical industry situated in Mumbai, India. Since its inception in 1976, the company has been dedicated to the development, manufacturing, and marketing of a wide array of pharmaceutical formulations and active pharmaceutical ingredients. It serves a diverse range of therapeutic segments, establishing a significant presence both domestically in India and in international markets. Lyka Labs stands out not only for its comprehensive product lineup but also for its contracted manufacturing services, which cater to the demands of large pharmaceutical companies. By providing medical and technical assistance, including manufacturing know-how, stability testing data, and clinical study data, the company has positioned itself as a go-to partner for pharmaceutical innovations and solutions.

Products and Services

Lyka Labs Limited offers a versatile range of products and services that cater to various medical and cosmetic needs:

  • Pharmaceutical Formulations: Range of formulations including emollient, topical steroid, antifungal agents, and more, addressing a wide spectrum of dermatological and medical conditions.
  • Active Pharmaceutical Ingredients: High-quality ingredients used for the manufacturing of drugs, serving various therapeutic categories.
  • Contract Manufacturing Services: Customized manufacturing solutions for large pharmaceutical companies, encompassing everything from production to packaging.
  • Medical and Technical Assistance: Support in manufacturing technologies, molecule stability testing, impurity profile analysis, and clinical study data.
  • Therapeutic Categories: Products and services extending across intensive care, gastroenterology, anti-infectives, and more, reflecting the company's holistic approach to healthcare.
  • Formulation Types: Diverse product forms including injections, creams, ointments, foams, gels, lotions, ensuring versatility in drug administration.

The company's dedication to innovation is evident in its extensive product portfolio, which includes dermatological formulations, pain killers, anti-aging treatments, hair care solutions, and cosmeceuticals among others. Each product is developed with a focus on efficacy, safety, and quality, helping Lyka Labs to maintain its reputation as a trusted name in the pharmaceutical industry.

Contact Information

Address: Spencer Building, Mumbai, India, 400036
Phone: 91 22 6611 2200